Adult Acne in Indian Women: Causes, Treatments and Honest Care

• Adult acne affects roughly 15-30% of adult women and is about five times more common in women than men, driven mostly by hormones, genetics, sebum and inflammation rather than cleanliness or diet.
• Hormones are the biggest driver: PCOS (which affects around 1 in 10 Indian women), premenstrual flares, and the relative androgen rise of perimenopause typically cause jawline-and-chin acne.
• Topical retinoids plus benzoyl peroxide or a topical antibiotic are first-line; oral antibiotics, combined contraceptive pills and spironolactone are added for moderate-to-severe or clearly hormonal acne.
• Isotretinoin is the most effective treatment for severe, scarring or treatment-resistant acne, but it is a Category X teratogen and requires strict, non-negotiable pregnancy prevention.
• Indian (Fitzpatrick IV-VI) skin marks easily, so daily SPF 50+ sunscreen and not picking lesions matter as much as the acne treatment itself for preventing dark spots.
• Effective care is available across a wide budget in India, from free government dermatology to private clinics; expensive chain-clinic packages rarely beat a thoughtful evidence-based routine.

Adult acne is acne in women aged 25 and older, whether it has persisted from the teenage years or appeared for the first time in adulthood. It affects around 15-30% of adult women across studies and is roughly five times more common in women than in men. The underlying biology is the same as teenage acne but the drivers differ.

A spot forms through four steps: androgens stimulate the sebaceous glands to produce more sebum (oil); the follicle opening clogs as skin cells build up (hyperkeratinisation); Cutibacterium acnes bacteria multiply in the blocked pore; and inflammation develops. The result ranges from non-inflammatory comedones (whiteheads and blackheads) to inflammatory papules, pustules, and deep, painful nodules and cysts.

Adult acne also sits differently on the face. Teenage acne tends to cluster in the oily T-zone (forehead, nose, chin), while adult acne often favours the lower face, jawline, chin and around the mouth, and sometimes the neck and upper back. This jawline pattern is the classic 'hormonal acne' distribution in adult women.

The most common contributors in adult women are hormonal. PCOS raises androgens and drives oily, inflammatory acne, often alongside irregular periods, excess facial and body hair and hair thinning. Cyclical hormone shifts cause premenstrual flares, and the relative androgen excess of perimenopause can trigger first-ever acne in the 40s. Genetics, comedogenic cosmetics, over-cleansing that damages the skin barrier, and hair oils that run onto the forehead all play a part.

Stress is well documented to worsen acne through cortisol and androgen effects. Diet has a modest role: a high-glycaemic-load diet (refined carbs, sugary drinks) and, in some people, dairy may aggravate acne, but neither is the cause for most women. Certain medicines (corticosteroids, lithium, some anticonvulsants and progestin-only contraceptives), friction from masks or helmets, and humidity can all flare acne too. Rarely, sudden severe acne with deepening voice or rapid excess hair growth signals an androgen-secreting tumour and needs urgent assessment. The honest framing is simple: adult acne is a medical condition with identifiable causes, and effective treatments exist.

Hormones are the single biggest driver of adult acne in women, and identifying the specific hormonal pattern guides effective treatment.

PCOS. Polycystic ovary syndrome affects roughly 1 in 10 Indian women of reproductive age. The hyperandrogenism (raised testosterone and DHT) stimulates sebum and inflammatory acne, classically along the jawline and chin. Suggestive features include irregular or absent periods, excess facial and body hair, androgenetic hair loss, weight gain and insulin resistance. Workup usually includes a hormone panel (total and free testosterone, DHEAS, SHBG, prolactin, TSH, sometimes 17-hydroxyprogesterone), fasting glucose and HbA1c, a lipid panel and pelvic ultrasound (around INR 1,500-4,000 at private labs, free at government hospitals). Treatment combines PCOS management with acne-specific therapy.

Cyclical (premenstrual) acne. Many women with regular cycles notice deep, painful spots on the jawline and chin in the week before their period, driven by progesterone effects on sebum and inflammation. The fix is consistent daily acne treatment rather than spot-treating only during flares, with hormonal regulation if appropriate.

Perimenopausal acne. As menopause approaches, oestrogen falls faster than androgens, creating a relative androgen excess that can trigger new acne or worsen existing acne, again in the jawline-and-chin pattern. Some women get their first-ever acne in their 40s. Standard topical treatments help, spironolactone is often well tolerated in this group, and for women with menopausal symptoms an HRT discussion is reasonable (acne is not the primary indication).

Pregnancy and postpartum. Pregnancy hormones affect acne unpredictably, and many oral and topical treatments are off-limits, so pregnancy needs its own approach; see our guide to acne in pregnancy and pregnancy-safe skincare. Postpartum hormone shifts commonly trigger flares. Other hormonal triggers worth knowing: stopping combined pills can cause a rebound that lasts months, progestin-only contraceptives sometimes worsen acne, and anabolic steroids (including hidden compounds in some bodybuilding supplements) cause severe acne.

The reassuring point is that hormonally driven acne often responds excellently to hormone-modulating treatments such as combined contraceptive pills with anti-androgen progestins, or spironolactone, when topical treatments alone are not enough.

A thoughtful first dermatology visit identifies the right treatment approach. Expect questions about when the acne started, your flare pattern (premenstrual, stress-related, seasonal), previous treatments and their effect, your current skincare and products, your cycle pattern and any irregularity, any signs of a hormonal condition, your pregnancy and contraception plans, current medicines, and family history.

The examination assesses severity (mild, moderate or severe), distribution, lesion types (comedonal, inflammatory, nodulocystic), and crucially for Indian skin, any scarring and post-inflammatory hyperpigmentation. Sometimes excess-hair scoring (Ferriman-Gallwey) is included.

Investigations are usually unnecessary for typical adult acne. When a hormonal cause is suspected, a hormone panel (total testosterone, free testosterone, DHEAS, SHBG, prolactin, TSH, sometimes 17-hydroxyprogesterone) is taken, ideally in the early follicular phase (cycle days 2-5), often with fasting glucose, HbA1c and a lipid panel; a pelvic ultrasound can confirm PCOS. Before isotretinoin, baseline liver function, lipids, a full blood count and a pregnancy test are mandatory.

Where to go in India: government dermatology departments at AIIMS, medical colleges and district hospitals offer care free or at minimal cost. Single-practice and hospital dermatologists (Apollo, Fortis, Manipal, Max, Medanta) typically charge INR 500-3,000 for a first visit and INR 300-1,500 for follow-up. Chain skin clinics (Kaya, VLCC, Oliva, ClearSkin and others) often give a free first consultation and then sell paid packages, so do not feel pressured to buy a package without an independent assessment.

Set realistic expectations: most acne treatments take 6-12 weeks to show visible improvement and 3-6 months for full effect. Photo tracking (with consent) helps. Red flags that warrant more aggressive workup or referral include rapid-onset severe acne with virilisation (deepening voice, severe hirsutism, scalp balding), acne not responding to standard treatment, severe scarring, and significant psychological distress.

Topical treatments are first-line for mild-to-moderate adult acne and stay important even when oral treatments are added. The foundation is a topical retinoid plus benzoyl peroxide or a topical antibiotic.

Topical retinoids are the most evidence-based class. Tretinoin (Retino-A, Eudyna, A-Ret; INR 100-300) is the gold standard, applied at night, starting twice a week and building up as tolerated. It speeds skin turnover, clears comedones and calms inflammation. Expect irritation, peeling, sun sensitivity and an initial 'purge' (temporary worsening in weeks 2-6); use sunscreen daily and never use it in pregnancy. Adapalene (Differin, Adaferin; INR 200-500) is a better-tolerated synthetic retinoid. Tazarotene is stronger but less common in India. Cosmetic retinol is milder and more accessible but less effective.

Topical antibiotics such as clindamycin 1% (Clindac-A, Erytop; INR 100-300) reduce C. acnes and inflammation but must always be paired with benzoyl peroxide or a retinoid to limit antibiotic resistance; they are safe in pregnancy. Benzoyl peroxide 2.5-5% (Persol, Benzac AC; INR 100-300) kills bacteria with no resistance problem; start low to limit irritation, and note it can bleach fabric and hair.

Combination products are popular and effective: clindamycin + benzoyl peroxide (Faceclin, Clindoxyl), clindamycin + adapalene (Deriva-CMS), and adapalene + benzoyl peroxide (Epiduo). Azelaic acid 15-20% (Aziderm, Skinoren; INR 300-800) treats inflammatory acne and dark marks, is safe in pregnancy, and is especially useful for Indian skin. Salicylic acid, glycolic acid and niacinamide serums add gentle exfoliation, sebum control and help with pigmentation.

A practical starter routine: gentle cleanser morning and night; a retinoid at night; benzoyl peroxide or a topical antibiotic in the morning; a barrier-friendly moisturiser (Cetaphil, Sebamed, CeraVe, Bioderma; INR 400-1,500); and a daily tinted SPF 50+ sunscreen with iron oxides, which protects Indian skin against both UV and visible light and helps prevent the dark marks discussed in our guide to melasma and pigmentation in Indian skin. Apply a pea-sized amount of retinoid to the whole face, not just spots, and give the routine 6-12 weeks of consistent use before judging it.

Importantly, never use over-the-counter steroid creams (Betnovate, Quadriderm, Panderm) for acne. They seem to help briefly but cause steroid acne, skin thinning, visible veins and rebound flares, and their misuse is a major cause of skin damage in India.

When topical treatment alone is not enough, oral treatment is added.

Oral antibiotics suit moderate-to-severe inflammatory acne. Doxycycline 100 mg daily (Doxy, Doxin; INR 50-200/month) is first-line, with antibacterial and anti-inflammatory effects; take it with food, expect possible photosensitivity and stomach upset, avoid it in pregnancy and breastfeeding, and limit courses to 3-4 months while continuing a topical to curb resistance. Minocycline is an alternative (watch for dizziness and, with long use, pigmentation). Azithromycin or erythromycin are options when tetracyclines are unsuitable, including in pregnancy.

Hormonal therapy is often dramatically effective for adult women with a hormonal pattern. Combined oral contraceptive pills with anti-androgen progestins help acne: Diane-35 (cyproterone acetate + ethinylestradiol; INR 100-300/month) has the strongest anti-androgen effect, while drospirenone pills (Yamini, Krimson 35; INR 150-400/month) are well tolerated and commonly prescribed. The usual combined-pill cautions apply (smoking over age 35, history of clots, migraine with aura, uncontrolled hypertension, breast cancer); our guide to birth control pills in India covers choosing one.

Spironolactone (Aldactone; INR 100-300/month) is an anti-androgen, usually dosed 50-200 mg/day for acne, and is very effective for the hormonal jawline pattern, often alongside topicals. Side effects include menstrual irregularity (often managed by combining it with a combined pill), breast tenderness and increased urination. It is absolutely contraindicated in pregnancy because of feminising effects on a male fetus, so reliable contraception (a combined pill or a copper IUD) is essential while taking it. Combined pills and spironolactone are frequently used together for severe hormonal acne, giving both anti-androgen action and contraception.

Because PCOS underlies so much adult acne, addressing it in parallel pays off; see our practical guides to PCOS treatment options and the anti-PCOS diet that actually works. The choice between antibiotic, hormonal therapy and isotretinoin depends on the pattern and severity, and pregnancy plans must be discussed before starting some of these treatments.

Isotretinoin (Sotret, Isotroin, Saheal, Accutane; INR 300-1,500/month) is by far the most effective acne treatment and deserves its own section because it has unique requirements. It is appropriate for severe nodulocystic acne, acne causing scarring or marked pigmentation, acne that has not responded to adequate topical, antibiotic and hormonal therapy, and acne causing significant psychological distress (a valid indication in its own right).

It works by sharply reducing sebum, normalising the follicle lining and calming inflammation. The usual dose is 0.5-1 mg/kg/day for 16-30 weeks, aiming for a cumulative dose of 120-150 mg/kg; lower doses over longer periods are sometimes used in older women with milder disease. Most people achieve permanent or long-lasting clearance after a single course.

The most important rule is absolute: isotretinoin is a Category X teratogen that causes severe birth defects (craniofacial, cardiac, central nervous system). Effective contraception is mandatory throughout treatment and for one month after, two negative pregnancy tests are needed before starting, and pregnancy is rechecked before each prescription. Two forms of contraception are ideal; many women use a copper or hormonal IUD for reliability. If you hope to conceive within a year or two, isotretinoin is not the right choice now; after a course, wait at least one month before trying.

Other side effects are common but manageable: dry lips (use lip balm constantly), dry skin and eyes, photosensitivity (daily SPF 50+), occasional muscle or joint aches, nosebleeds, and an initial purge in weeks 2-6. Triglycerides and liver enzymes are checked monthly and usually settle on stopping. A possible link with mood changes, including depression, has been reported but remains debated; a baseline mental-health check is sensible and any significant mood change should be reported promptly. If acne is weighing on your mental health, support for depression and anxiety alongside treatment is entirely reasonable.

Cost in India is accessible: a full medication course runs roughly INR 2,000-15,000 (generic Saheal is cheapest), plus monthly visits and blood tests. The most affordable route is government dermatology with a generic brand. The honest framing is that isotretinoin is genuinely transformative for severe or stubborn acne, its side effects are manageable with attention, and its pregnancy-prevention rules are non-negotiable.

Procedures work best as adjuncts to medical treatment, both for active acne and for post-acne marks and scars. On Indian (Fitzpatrick IV-VI) skin they should be done by an experienced practitioner to minimise the risk of triggering more pigmentation.

Chemical peels use controlled acid solutions to exfoliate and renew skin. Common agents include glycolic, lactic, mandelic (gentle and well tolerated in deeper skin tones) and salicylic acid. A typical course is 4-6 peels at 2-4 week intervals, with sessions around INR 500-3,000.

Microneedling creates controlled micro-injuries to stimulate collagen, helping rolling and boxcar scars and pigmentation; sessions run about INR 3,000-8,000, with radiofrequency microneedling (Morpheus 8) costing more for deeper scars. Intralesional steroid injection (dilute triamcinolone) flattens individual large painful cysts within a day or two at around INR 200-1,000 per injection.

Lasers and light include low-fluence Q-switched Nd:YAG for pigmentation, fractional non-ablative lasers for scars, and fractional CO2 for deeper scars. IPL carries a real risk of paradoxically worsening pigmentation in darker skin and should be used cautiously, if at all.

A cost-effective reality check: for most women with post-acne marks, a good topical routine (retinoid, vitamin C, sunscreen) plus the occasional chemical peel delivers 60-80% of the achievable improvement at a fraction of the cost of laser packages. Many chain clinics aggressively market scar packages costing INR 50,000 to over a lakh that add little over a thoughtful topical approach; reserve expensive lasers for cases that have genuinely plateaued.

Post-inflammatory hyperpigmentation (PIH) is the dark marks left after acne heals, and it is far more common and longer-lasting in Indian skin than in lighter skin types. Acne inflammation prompts melanocytes to overproduce melanin in the affected area, and in deeper skin tones this response is stronger and lasts months to years. For many women the marks are more distressing than the active acne.

Prevention is the most powerful intervention: treat acne promptly to limit inflammation, never pick or squeeze lesions, use a daily broad-spectrum tinted SPF 50+ sunscreen with iron oxides (UV and visible light both darken PIH), and keep skincare gentle. This overlaps closely with managing other pigmentation; our melasma and pigmentation guide and the pregnancy mask (chloasma) guide cover the same protective principles.

For established marks, topical retinoids speed pigment clearance and are first-line. Vitamin C serums brighten and add antioxidant protection, azelaic acid is anti-inflammatory and pigment-reducing (and pregnancy-safe), and niacinamide reduces melanin transfer. Hydroquinone 2-4% is the gold-standard depigmenting agent but should be used under dermatologist supervision in 8-12 week courses with breaks; it is not for pregnancy. The classic 'triple combination' (hydroquinone + tretinoin + a mild steroid) is effective but needs supervision because of the steroid. Gentle peels (mandelic, glycolic, salicylic) and low-fluence laser toning help diffuse PIH.

Be patient: most PIH improves substantially over 3-12 months with consistent topicals and sun protection. Consistency beats aggression, which can worsen pigmentation.

A clear body-positive line matters here. Indian skin tone is healthy biology, not a flaw. Treating the specific dark spots left by acne is reasonable medicine; trying to lighten your overall complexion is a different and harmful goal that the fairness-cream industry deliberately blurs by selling depigmenting products as 'acne and mark' solutions. Target the marks, not your natural skin tone.

Effective adult acne care is achievable across a wide budget in India. The public sector offers excellent value: government dermatology departments (AIIMS, medical colleges, district hospitals) provide consultations and basic medicines free or at minimal cost, and isotretinoin is available cheaply through government pharmacies. ESI hospitals and Ayushman Bharat help eligible beneficiaries.

Private consultations run INR 500-2,000 (first visit) at a single-dermatologist clinic, more for senior dermatologists in metros, and INR 800-3,000 at multi-specialty hospitals. Chain skin clinics often start free and then sell packages, so get an independent view before committing.

Typical monthly medication costs: topical retinoids INR 100-500; topical antibiotics and benzoyl peroxide INR 100-300; azelaic acid INR 300-800; vitamin C and niacinamide serums INR 400-3,000; doxycycline INR 50-200; combined pills (Diane-35, Yamini) INR 100-400; spironolactone INR 100-300; isotretinoin INR 300-1,500. A tinted SPF 50+ sunscreen costs INR 500-1,500 and a barrier moisturiser INR 400-2,000.

Most basic health insurance does not cover routine acne but may cover severe acne with complications; some employer policies include dermatology benefits. A sensible budget plan: for mild-to-moderate acne, government dermatology plus a topical routine for INR 500-1,500/month; for a hormonal pattern, add spironolactone or a combined pill for INR 100-400/month; for severe acne, a generic isotretinoin course at INR 2,000-15,000; and for marks, topicals plus the occasional peel before considering lasers. The bottom line: good evidence-based care does not require a big budget, and the most expensive option is rarely the most effective.

Adult acne carries real social weight in India, where 'clear skin' is heavily prized, especially for young women approaching marriage. None of that pressure changes the biology: adult acne is a medical condition driven by hormones, genetics, sebum and inflammation, not a sign of poor hygiene, bad food choices or insufficient self-care.

The common messages that deepen the burden are mostly myths. 'You must be doing your skincare wrong' is usually untrue when acne is hormonally driven. 'It's your diet' overstates a modest effect. 'You won't get married with this skin' is harmful and false. And the fairness-cream industry exploits acne and its marks to sell complexion-lightening products, conflating a treatable medical condition with a cultural preference for lighter skin. They are not the same thing.

The psychological impact is real and valid: acne is linked with anxiety, low mood, social withdrawal and body-image distress, often out of proportion to how it looks. That distress is itself a legitimate reason for active treatment, and support for depression and anxiety or counselling alongside dermatology care is entirely appropriate. Understanding the link between hormones and mental health can also help make sense of cyclical mood and skin changes together.

Practical anti-shame strategies: reframe acne as something you have, not something you are; choose a dermatologist who treats you respectfully and uses evidence-based care; set boundaries with relatives who comment on or shame your skin ('I'm seeing a dermatologist who has explained this is a medical condition being treated'); decline unproven 'miracle' or fairness products without guilt; and use concealer or makeup if it helps your confidence, as a reasonable tool rather than a failure. Seek good treatment, give it time, and remember your worth is not your skin.

• American Academy of Dermatology — Acne: Diagnosis and Treatment
• American Academy of Dermatology — Guidelines of Care for the Management of Acne Vulgaris (2024)
• NHS — Acne
• DermNet NZ — Acne in adult women
• World Health Organization — Polycystic ovary syndrome (PCOS) fact sheet
• International Evidence-Based Guideline for the Assessment and Management of PCOS (2023)